Parmax Pharma Ltd. - PARMAX, 540359 corporate action history

Parmax Pharma Ltd.

BSE: 540359 | GSM

Download real time

45.66 0.26 (0.57%)

82.42% Gain from 52W Low

46 BSE Volume

BSE 02 Jun, 2025 3:31 PM (IST)

17.1

Market Cap

Low in industry

0.0

Beta 1Year

Very Low volatility

Parmax Pharma Ltd. Bonus history

Parmax Pharma Ltd. has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Parmax Pharma Ltd. Split history

Parmax Pharma Ltd. has not split the face value of the share since Jan 1, 2000.

See all forthcoming Bonus and Splits

Parmax Pharma Ltd. Dividend history

Parmax Pharma Ltd. has not given any dividends since Jan 1, 2000.

See all forthcoming dividends

Board Meetings - Parmax Pharma Ltd.

The latest board meeting for Parmax Pharma Ltd. took place on 30 May 2025, for the purpose of Audited Results

Ex-Date	Purpose	Notes
30 May 2025	Audited Results	-
14 Feb 2025	Quarterly Results	-
14 Nov 2024	Quarterly Results	-
14 Aug 2024	Quarterly Results	-
30 May 2024	Audited Results	(Revised)
14 Feb 2024	Quarterly Results	-
10 Nov 2023	Quarterly Results	-
14 Aug 2023	Quarterly Results	-
30 May 2023	Audited Results	-
11 Feb 2023	Quarterly Results	-

See all Board Meetings for Parmax Pharma Ltd.

Parmax Pharma Ltd. Rights history

Parmax Pharma Ltd. has not issued any rights since Jan 1, 2000.

See all Rights History for Parmax Pharma Ltd.

Is Parmax Pharma Ltd. worth buying?

4 Votes:

Buy 25.0%

Sell 25.0%

Hold 50.0%